Dividend
-
-
-
-
-
-
-
Amgen (AMGN) Cytokinetics (CYTK) and Servier Report Continuation of GALACTIC-HF Following Planned Interim Analysis
-
-
-
-
-
-
-
Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis
-
-
-
-
-
-
-
The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function in Patients With Chronic Heart Failure
-
-
-
-
-
-
-
Notable 52-Week Highs and Lows of the Day 06/18: (CYTK) (GE) (SPRD) High; (FIO) (LINE) (PANW) Low
-
-
-
-
-
377,510 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All